Market Cap 127.78M P/E - EPS this Y 59.90% Ern Qtrly Grth -
Income -126.35M Forward P/E -30.09 EPS next Y 92.90% 50D Avg Chg -67.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -79.00%
Dividend N/A Price/Book 0.94 EPS next 5Y - 52W High Chg -93.00%
Recommedations 3.20 Quick Ratio 5.81 Shares Outst. 38.60M 52W Low Chg 10.00%
Insider Own 3.51% ROA -44.66% Shares Float 16.67M Beta 0.34
Inst Own 96.04% ROE -84.67% Short Shares 0 Price 3.31
Gross Margin - Profit Margin - Avg. Volume 4,231,543 Target Price 4.00
Oper. Margin - Earnings Apr 26 Volume 475,254 Change 0.00%
Odonate Therapeutics, Inc. News
04/11/21 3 Critical Things Investors Should Look for Before Buying Clinical-Stage Biotech Stocks
04/09/21 Odonate Therapeutics (ODT) is Oversold: Can It Recover?
04/08/21 Is Odonate Therapeutics (NASDAQ:ODT) In A Good Position To Invest In Growth?
03/24/21 Do Options Traders Know Something About Odonate Therapeutics (ODT) Stock We Don't?
03/22/21 Why GRPN Stock And ODT Stock Are Trading Lower Today
03/22/21 Odonate Therapeutics stock plummets toward record low after plan to 'wind down' operations
03/22/21 Why Odonate Therapeutics Stock Is Crashing Today
03/22/21 Odonate Therapeutics Announces Discontinuation of Development of Tesetaxel
02/23/21 Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020
01/02/21 Craig Johnson Is The Independent Director of Odonate Therapeutics, Inc. (NASDAQ:ODT) And Just Spent US$51k On Shares
01:06 PM Is ODT A Good Stock To Buy Now According To Hedge Funds?
12/17/20 BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
12/11/20 Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
12/07/20 Odonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastatic Breast Cancer
12/01/20 Odonate Therapeutics to Host Virtual Investor and Analyst Event on December 11, 2020
11/16/20 ODT Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Odonate Therapeutics, Inc. Shareholders With Losses Exceeding $50K of Class Action and Lead Plaintiff Deadline: November 16, 2020
11/16/20 ODT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 16, 2020 in the Class Action Filed on Behalf of Odonate Therapeutics, Inc. Limited Shareholders
11/16/20 FINAL DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Odonate Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
11/16/20 FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Odonate Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer; and CONTESSA 2 and CONTESSA TRIO, which is in Phase II clinical study for central nervous system metastases and various cancer treatments. The company was founded in 2013 and is based in San Diego, California.

ODT Chatroom

User Image WidowPuppy Posted - 30 minutes ago

$ODT When they sever the next limb, should cause massive blood flow.

User Image intratio Posted - 39 minutes ago The predictive algorithm foresees that this stock price will go south in the coming week and has a neutral long term price outlook $ODT

User Image David77777 Posted - 1 hour ago

$ODT rating aised to buy, price target $50!

User Image Drsaeed Posted - 2 hours ago

$ODT it is the time to buy more and moreπŸ’΅πŸ’΅πŸ’΅πŸ’΄πŸ˜πŸ˜πŸ‘πŸ˜€πŸ’΅πŸ’΅πŸ’°

User Image Shoooooooort Posted - 2 hours ago

$ODT Dear old friend ... red, red, red

User Image David77777 Posted - 3 hours ago

$ODT at this low price has 18% more cash than it's market cap. A total steal of a buy and rightly upgraded to buy with rsi<23!

User Image Morez Posted - 4 hours ago

$ODT Sell $5 and $7.5 distant calls against your long position(July, Oct). They become worthless in June and you'll pocket free money and make your average lower to sustain potential downside if any occurs. Though I do not see big downside here

User Image WidowPuppy Posted - 5 hours ago

$ODT Congrats if you escaped 10 minutes ago.

User Image Shoooooooort Posted - 5 hours ago


User Image David77777 Posted - 5 hours ago

$ODT $ODT at this low price has 18% more cash than it's market cap. A total steal of a buy and rightly upgraded to buy with rsi<23!

User Image MoneyMoodz Posted - 5 hours ago

Watching PreMarket and at Open: πŸ“°πŸ‘€πŸ€”. $TNXP $ODT $CSCW $CLNE $ANPC πŸ€·β€β™€οΈ

User Image PirloReis Posted - 6 hours ago

$ODT when we gonna see gap up?

User Image WidowPuppy Posted - 7 hours ago

$ODT Absolute destruction.

User Image Swing_Tradez Posted - 7 hours ago

$IDRA risk reward SL under 52-week low ww this week no position yet $AHT $ODT $WIMI

User Image Swing_Tradez Posted - 8 hours ago

$AHT ww holding $WIMI and $ODT last couple of months has had its ups and downs. Still alive and learning, life’s good!

User Image AroonOscar22 Posted - 15 hours ago

$ODT Why waste money investing in Odonate when you could invest in medical cannabis?

User Image AroonOscar22 Posted - 15 hours ago


User Image WidowPuppy Posted - 19 hours ago

$ODT Tomorrow, we finish this once and for good!

User Image Swing_Tradez Posted - 19 hours ago

$ODT adds on Friday, tomorrow looking to add 3.10 SL under 3 also holding $WIMI

User Image BidaskBot Posted - 20 hours ago

OdonateTherapeutics $ODT BidaskScore is #Reiterated to Sold

User Image AroonOscar22 Posted - 1 day ago

$ODT "On March 19, 2021...Odonate concluded that its clinical data package for tesetaxel is unlikely to support FDA approval." "Therefore, Odonate is discontinuing the development of tesetaxel and will wind down the operations of the Company."

User Image tickeron Posted - 2 days ago

Have you seen this? $ODT in -12.99% Downtrend, sliding for three consecutive days on April 13, 2021. View odds for this and other indicators:

User Image AroonOscar22 Posted - 2 days ago


User Image Gaining_Inversely_101 Posted - 2 days ago

$ODT anyone know how insider shares factor into a buyout? Do they work like shares outstanding and public float?

User Image ekabal Posted - 2 days ago

$ODT Why is it so difficult for these cs to understand that shutting down operations does not mean this company is worthless? I thought the case for buying especially at these levels, for less than the cash cushion (!) was quite clearly made. Downside:Very little Upside: double, triple, difficult to know Yes this is speculative, so dont take your kids lunch money to buy

User Image ekabal Posted - 2 days ago

$ODT What happened to the illiterate oaf that said this was going to a $1? Were they put back into the mental asylum"?

User Image Drsaeed Posted - 2 days ago

$ODT keep buying and holding one day we will reach the gap up $17πŸ’΅πŸ’΅πŸ’΅πŸ’°πŸ’΅πŸ’΅πŸ’΅

User Image MoneyMoodz Posted - 2 days ago

πŸ€”πŸ‘€Next WeekπŸ€·β€β™€οΈπŸ€ $CSCW $ODT $BCTX $EEIQ $TIRX

User Image intratio Posted - 3 days ago

$ODT Odonate Therapeutics Inc The engine calculated this equity value has an unfavorable short term setup and is facing significant downsides in the longer term

User Image WidowPuppy Posted - 3 days ago

$SKLZ $XL $AMC $ODT Just got take out that low to trigger the "oh no". Let's do this! Stocalypse, can you hear the trumpet?

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own
Dec 30, 6:19 PM Buy 17.16 400,000 6,864,000 5,607,086
Davis Aaron I. Director Director Dec 30, 6:18 PM Buy 17.16 400,000 6,864,000 5,607,086